Journal article

Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses

Anais Glatard, Monia U Gidi, Aurelie Delacretaz, Celine Dubath, Claire Grosu, Nermine Laaboub, Armin von Gunten, Philippe Conus, Chantal Csajka, Chin B Eap

CLINICAL PHARMACOKINETICS | ADIS INT LTD | Published : 2020

Abstract

BACKGROUND: Amisulpride is an antipsychotic used in a wide range of doses. One of the major adverse events of amisulpride is hyperprolactinemia, and the drug might also induce body weight gain. OBJECTIVE: The aims of this work were to characterize the pharmacokinetics of amisulpride in order to suggest optimal dosage regimens to achieve the reference range of trough concentrations at steady-state (Cmin,ss) and to describe the relationship between drug pharmacokinetics and prolactin and body weight data. METHODS: The influence of clinical and genetic characteristics on amisulpride pharmacokinetics was quantified using a population approach. The final model was used to simulate Cmin,ss under s..

View full abstract